Beyond BRAFV600: Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma

Alan Siroy(The University of Texas MD Anderson Cancer Center), Genevieve M. Boland(The University of Texas MD Anderson Cancer Center), Denái R. Milton(The University of Texas MD Anderson Cancer Center), Jason Roszik(The University of Texas MD Anderson Cancer Center), Silva Frankian(The University of Texas MD Anderson Cancer Center), Jared Malke(The University of Texas MD Anderson Cancer Center), Lauren E. Haydu(The University of Texas MD Anderson Cancer Center), Víctor G. Prieto(The University of Texas MD Anderson Cancer Center), Michael T. Tetzlaff(The University of Texas MD Anderson Cancer Center), Doina Ivan(The University of Texas MD Anderson Cancer Center), Wei‐Lien Wang(The University of Texas MD Anderson Cancer Center), Carlos A. Torres‐Cabala(The University of Texas MD Anderson Cancer Center), Jonathan L. Curry(The University of Texas MD Anderson Cancer Center), Sinchita Roy‐Chowdhuri(The University of Texas MD Anderson Cancer Center), Russell R. Broaddus(The University of Texas MD Anderson Cancer Center), Asif Rashid(The University of Texas MD Anderson Cancer Center), John Stewart(The University of Texas MD Anderson Cancer Center), Jeffrey E. Gershenwald(The University of Texas MD Anderson Cancer Center), Rodabe N. Amaria(The University of Texas MD Anderson Cancer Center), Sapna P. Patel(The University of Texas MD Anderson Cancer Center), Nicholas E. Papadopoulos(The University of Texas MD Anderson Cancer Center), Agop Y. Bedikian(The University of Texas MD Anderson Cancer Center), Wen-Jen Hwu(The University of Texas MD Anderson Cancer Center), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Adi Diab(The University of Texas MD Anderson Cancer Center), Scott E. Woodman(The University of Texas MD Anderson Cancer Center), Kenneth Aldape(The University of Texas MD Anderson Cancer Center), Rajyalakshmi Luthra(The University of Texas MD Anderson Cancer Center), Keyur P. Patel(The University of Texas MD Anderson Cancer Center), Kenna Shaw(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), John Mendelsohn(The University of Texas MD Anderson Cancer Center), Funda Meric‐Bernstam(The University of Texas MD Anderson Cancer Center), Kevin B. Kim(The University of Texas MD Anderson Cancer Center), Mark J. Routbort(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center)
Journal of Investigative Dermatology
August 22, 2014
Cited by 149Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis